Physician

Andres Wilfredo Bhatia, MD

According to 2025 Medicare claims, Andres Bhatia, MD (NPI: 1700872710) practices hematology/oncology in the Gainesville, FL market, with the plurality of this provider's patient population coming from Alachua, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 32605-4308. Bhatia is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), participating under the MSSP model.

Bhatia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,718 traditional Medicare patients, billed 450,983 HCPCS/CPT codes, and received $5,480,610 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,086 prescription claims across 369 beneficiaries totaling $4,315,599 in drug costs, led by Revlimid (Lenalidomide). DME data shows 33 claims. Open Payments data shows 21 records totaling $402. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $3,643,466 to $5,480,610. Similarly, Part D prescription costs have risen steadily, from $1,347,143 to $4,315,599. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $15,961 to $1,925.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,823	310,929	$3,643,466
2016	1,748	347,525	$3,848,963
2017	1,551	266,920	$3,500,407
2018	1,580	420,203	$3,695,877
2019	1,480	493,871	$4,227,098
2020	1,250	446,458	$4,050,721
2021	1,149	421,595	$4,175,539
2022	1,121	338,293	$3,740,223
2023	1,392	413,636	$5,554,896
2024	1,718	450,983	$5,480,610

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	330	2,084	$1,347,143
2016	312	1,958	$2,069,125
2017	279	1,667	$2,357,687
2018	257	1,499	$2,768,747
2019	233	1,271	$2,216,163
2020	257	1,483	$2,466,084
2021	257	1,342	$2,360,927
2022	280	1,668	$3,659,810
2023	318	1,708	$3,659,406
2024	369	2,086	$4,315,599

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	187	$59,794
2016	15	150	$22,324
2017	13	84	$4,816
2018	11	53	$8,214
2019	15	31	$4,346
2020	N/R	51	$7,255
2021	N/R	143	$43,974
2022	N/R	16	$1,469
2023	11	26	$3,152
2024	N/R	33	$1,321

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	776	1,231	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	696	1,042	$63
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	289	319	$13
36415	Insertion of needle into vein for collection of blood sample	1,266	3,741	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	1,267	3,952	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	36	917	$574,725
Pomalyst	Pomalidomide	22	616	$511,208
Imbruvica	Ibrutinib	22	616	$318,030
Lenvima	Lenvatinib Mesylate	13	390	$315,622
Piqray	Alpelisib	11	336	$267,394

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	11	$862
K0001	Standard wheelchair	Y	N/R	11	$328
K0195	Elevating leg rests, pair (for use with capped rental wheelchair base)	Y	N/R	11	$131

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$402	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andres Wilfredo Bhatia, MD?

Tedicare shows public-source Medicare data for Andres Wilfredo Bhatia, MD (NPI 1700872710), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andres Wilfredo Bhatia, MD have ACO affiliation data?

Andres Wilfredo Bhatia, MD is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591).

What billing organization is linked to Andres Wilfredo Bhatia, MD?

Andres Wilfredo Bhatia, MD is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Andres Wilfredo Bhatia, MD have Open Payments data?

Andres Wilfredo Bhatia, MD has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.